Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Tracy Britt Cool says Cambric uses a 15-plus-year structure so investors and business owners self-select for long horizons. The fund can return capital through recaps—JM Test returned its initial investment while Cambric still owned more than 70% of the business—without forcing a premature sale early.

Related Insights

Beyond the thesis, first-time biotech funds must explicitly align with LPs on the 6-to-9-year journey from seed to exit. Daniel Fero stresses finding LPs who understand their capital will be locked up for a long duration, unlike in crossover funds with shorter horizons. This "psychological fit" on capital flow expectations is crucial for a stable fund.

The biggest venture outcomes often take 8-10 years or more to mature. Instead of optimizing for quick IRR, early-stage VCs should embrace long holding periods. This "duration" is a feature that allows for massive value creation and aligns with building truly transformative companies, prioritizing multiples over short-term gains.

Unlike traditional private equity firms with a 3-5 year exit timeline, Long Lake is structured as a permanent capital operating company. This allows them to make the necessary long-term, upfront investments in AI and technology to fundamentally transform the businesses they acquire.

A key evolution in private equity is holding top companies beyond the typical fund lifecycle. Continuation vehicles allow firms to retain their "trophy assets," offering liquidity to LPs who want to exit while allowing the firm and other LPs to benefit from continued growth.

Maloa's "endless" investment model acquires 30-40% minority stakes in businesses without using leverage or imposing exit timelines. It prioritizes annual cash distributions to investors over a single large liquidity event, aligning all parties around sustainable, long-term growth.

Top companies like Stripe are staying private for decades, extending the time VCs need to return capital to LPs. This shift from a 7-9 year cycle to a 16-20 year one fundamentally changes fund structure and liquidity expectations for both GPs and LPs.

The standard 5-year PE cycle is too short for the slow-to-change legal sector. A better model is minority patient capital: taking a 10-20% stake in a large, healthy firm for 10-15 years. The investor acts as a "super equity partner," collecting annual drawings while guiding long-term growth.

Unlike traditional funds that face pressure to deploy capital within a set timeframe, a HoldCo's greatest strategic advantage is patience. Value is created by waiting for the right opportunity at the right price, not by rushing to do deals.

The rigid 10-year fund model is outdated for companies staying private longer. The future is permanent capital vehicles with hedge fund-like structures, offering long durations and built-in redemption features for LPs who need liquidity.

When raising for a "civilization tech" company, Colossal purposefully avoided investors seeking 4-5 year fund returns. They targeted patient capital from system-builders like Jim Breyer and Thomas Tull, who have experience backing foundational technologies like the internet and quantum computing and understand multi-decade horizons for creating new economies.

Fifteen-year fund structure self-selects patient capital and owners | RiffOn